Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Barrett oesophagus.

Peters Y, Al-Kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD.

Nat Rev Dis Primers. 2019 May 23;5(1):35. doi: 10.1038/s41572-019-0086-z. Review.

PMID:
31123267
2.

Gastrointestinal Endoscopy Editorial Board top 10 topics: advances in GI endoscopy in 2018.

Cohen J, Desilets DJ, Hwang JH, Kyanam Kabir Baig KR, Leung FW, Maranki JL, Okolo PI 3rd, Swanstrom LL, Chak A.

Gastrointest Endosc. 2019 Jul;90(1):35-43. doi: 10.1016/j.gie.2019.03.020. Epub 2019 Mar 27.

PMID:
30928425
3.

Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.

Blum AE, Venkitachalam S, Ravillah D, Chelluboyina AK, Kieber-Emmons AM, Ravi L, Kresak A, Chandar AK, Markowitz SD, Canto MI, Wang JS, Shaheen NJ, Guo Y, Shyr Y, Willis JE, Chak A, Varadan V, Guda K.

Gastroenterology. 2019 May;156(6):1761-1774. doi: 10.1053/j.gastro.2019.01.263. Epub 2019 Feb 12.

PMID:
30768984
4.

Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees.

Wani S, Han S, Simon V, Hall M, Early D, Aagaard E, Abidi WM, Banerjee S, Baron TH, Bartel M, Bowman E, Brauer BC, Buscaglia JM, Carlin L, Chak A, Chatrath H, Choudhary A, Confer B, Coté GA, Das KK, DiMaio CJ, Dries AM, Edmundowicz SA, El Chafic AH, El Hajj I, Ellert S, Ferreira J, Gamboa A, Gan IS, Gangarosa L, Gannavarapu B, Gordon SR, Guda NM, Hammad HT, Harris C, Jalaj S, Jowell P, Kenshil S, Klapman J, Kochman ML, Komanduri S, Lang G, Lee LS, Loren DE, Lukens FJ, Mullady D, Muthusamy RV, Nett AS, Olyaee MS, Pakseresht K, Perera P, Pfau P, Piraka C, Poneros JM, Rastogi A, Razzak A, Riff B, Saligram S, Scheiman JM, Schuster I, Shah RJ, Sharma R, Spaete JP, Singh A, Sohail M, Sreenarasimhaiah J, Stevens T, Tabibian JH, Tzimas D, Uppal DS, Urayama S, Vitterbo D, Wang AY, Wassef W, Yachimski P, Zepeda-Gomez S, Zuchelli T, Keswani RN.

Gastrointest Endosc. 2019 Jun;89(6):1160-1168.e9. doi: 10.1016/j.gie.2019.01.030. Epub 2019 Feb 7.

PMID:
30738985
5.

Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study.

Cummings Iii KC, Kou TD, Chak A, Schluchter MD, Margevicius S, Cooper GS, Meropol NJ, Perry Y, Linden PA, Cummings LC.

PLoS One. 2019 Jan 22;14(1):e0211125. doi: 10.1371/journal.pone.0211125. eCollection 2019. Erratum in: PLoS One. 2019 Mar 21;14(3):e0214528.

6.

Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.

Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG.

Gastroenterology. 2019 Apr;156(5):1404-1415. doi: 10.1053/j.gastro.2018.12.004. Epub 2018 Dec 19.

PMID:
30578782
7.

A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma.

Duits LC, Lao-Sirieix P, Wolf WA, O'Donovan M, Galeano-Dalmau N, Meijer SL, Offerhaus GJA, Redman J, Crawte J, Zeki S, Pouw RE, Chak A, Shaheen NJ, Bergman JJGHM, Fitzgerald RC.

Dis Esophagus. 2019 Jan 1;32(1). doi: 10.1093/dote/doy102.

PMID:
30496496
8.

Characterization of long-term prognosis in acute pancreatitis: An explorative analysis.

Abou Saleh M, Chouhan V, Mansoor E, Guttikonda D, Natu A, Enzerra M, Paspulati R, Ngendahimana D, Alsuleiman B, Kang L, Glessing B, Chak A, Stevens T, Lee PJ.

Pancreatology. 2019 Jan;19(1):163-168. doi: 10.1016/j.pan.2018.09.017. Epub 2018 Oct 9.

PMID:
30396818
9.

Endoscopic Doppler Probe in the Diagnosis and Management of Upper Gastrointestinal Hemorrhage.

Satyavada S, Davitkov P, Akbar Ali M, Cooper G, Wong RCK, Chak A.

ACG Case Rep J. 2018 Sep 26;5:e68. doi: 10.14309/crj.2018.68. eCollection 2018.

10.

Is Mass Screening for Barrett's Esophagus a Myth or Reality?

Thota PN, Chak A.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):610-612. doi: 10.1016/j.cgh.2018.09.026. Epub 2018 Sep 26. No abstract available.

11.

Association of Vitamin D and Parathyroid Hormone With Barrett's Esophagus.

Rubenstein JH, McConnell D, Beer DG, Chak A, Metko V, Clines G.

J Clin Gastroenterol. 2019 Nov/Dec;53(10):711-716. doi: 10.1097/MCG.0000000000001124.

PMID:
30180151
12.

Competence in Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography, From Training Through Independent Practice.

Wani S, Keswani RN, Han S, Aagaard EM, Hall M, Simon V, Abidi WM, Banerjee S, Baron TH, Bartel M, Bowman E, Brauer BC, Buscaglia JM, Carlin L, Chak A, Chatrath H, Choudhary A, Confer B, Coté GA, Das KK, DiMaio CJ, Dries AM, Edmundowicz SA, El Chafic AH, El Hajj I, Ellert S, Ferreira J, Gamboa A, Gan IS, Gangarosa LM, Gannavarapu B, Gordon SR, Guda NM, Hammad HT, Harris C, Jalaj S, Jowell PS, Kenshil S, Klapman J, Kochman ML, Komanduri S, Lang G, Lee LS, Loren DE, Lukens FJ, Mullady D, Muthusamy VR, Nett AS, Olyaee MS, Pakseresht K, Perera P, Pfau P, Piraka C, Poneros JM, Rastogi A, Razzak A, Riff B, Saligram S, Scheiman JM, Schuster I, Shah RJ, Sharma R, Spaete JP, Singh A, Sohail M, Sreenarasimhaiah J, Stevens T, Tabibian JH, Tzimas D, Uppal DS, Urayama S, Vitterbo D, Wang AY, Wassef W, Yachimski P, Zepeda-Gomez S, Zuchelli T, Early D.

Gastroenterology. 2018 Nov;155(5):1483-1494.e7. doi: 10.1053/j.gastro.2018.07.024. Epub 2018 Jul 26.

PMID:
30056094
13.

Sham or no sham: the debate continues.

Lee PJ, Chak A.

Gastrointest Endosc. 2018 Jul;88(1):203-204. doi: 10.1016/j.gie.2018.02.002. No abstract available.

PMID:
29935620
14.

Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.

Yu M, Maden SK, Stachler M, Kaz AM, Ayers J, Guo Y, Carter KT, Willbanks A, Heinzerling TJ, O'Leary RM, Xu X, Bass A, Chandar AK, Chak A, Elliott R, Willis JE, Markowitz SD, Grady WM.

Gut. 2018 Jun 8. pii: gutjnl-2017-314544. doi: 10.1136/gutjnl-2017-314544. [Epub ahead of print]

PMID:
29884612
15.

Gastrointestinal Endoscopy Editorial Board top 10 topics: advances in GI endoscopy in 2017.

Desilets DJ, Hwang JH, Kyanam Kabir Baig KR, Leung FW, Maranki JL, Mishra G, Shah RJ, Swanstrom LL, Chak A.

Gastrointest Endosc. 2018 Jul;88(1):1-8. doi: 10.1016/j.gie.2018.04.2333. Epub 2018 May 18. No abstract available.

PMID:
29779609
16.

Association of sporadic and familial Barrett's esophagus with breast cancer.

Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/doy007.

17.

The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.

Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG.

Gastroenterology. 2018 Jun;154(8):2068-2086.e5. doi: 10.1053/j.gastro.2018.02.022. Epub 2018 Feb 16. Review.

18.

Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial.

Al-Kawas F, Aslanian H, Baillie J, Banovac F, Buscaglia JM, Buxbaum J, Chak A, Chong B, Coté GA, Draganov PV, Dua K, Durkalski V, Elmunzer BJ, Foster LD, Gardner TB, Geller BS, Jamidar P, Jamil LH, Keswani RN, Khashab MA, Lang GD, Law R, Lichtenstein D, Lo SK, McCarthy S, Melo S, Mullady D, Nieto J, Bayne Selby J, Singh VK, Spitzer RL, Strife B, Tarnaksy P, Taylor JR, Tokar J, Wang AY, Williams A, Willingham F, Yachimski P; In alphabetical order for the INTERCPT Study Group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE).

Trials. 2018 Feb 14;19(1):108. doi: 10.1186/s13063-018-2473-2.

19.

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.

Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaao5848. doi: 10.1126/scitranslmed.aao5848.

20.

Association of Statins With Decreased Acute Pancreatitis Severity: A Propensity Score Analysis.

Lee PJ, Modha K, Chua T, Chak A, Jang D, Lopez R, Gougol A, Papachristou GI, Stevens T.

J Clin Gastroenterol. 2018 Sep;52(8):742-746. doi: 10.1097/MCG.0000000000000956.

PMID:
29095423
21.

Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.

Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A.

PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017.

22.

Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.

Luebeck EG, Curtius K, Hazelton WD, Maden S, Yu M, Thota PN, Patil DT, Chak A, Willis JE, Grady WM.

Clin Epigenetics. 2017 Oct 16;9:113. doi: 10.1186/s13148-017-0409-4. eCollection 2017.

23.

A nonrandomized trial of vitamin D supplementation for Barrett's esophagus.

Cummings LC, Thota PN, Willis JE, Chen Y, Cooper GS, Furey N, Bednarchik B, Alashkar BM, Dumot J, Faulx AL, Fink SP, Kresak AM, Abusneineh B, Barnholtz-Sloan J, Leahy P, Veigl ML, Chak A, Markowitz SD.

PLoS One. 2017 Sep 18;12(9):e0184928. doi: 10.1371/journal.pone.0184928. eCollection 2017.

24.

A Prospective Multicenter Study Evaluating Learning Curves and Competence in Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography Among Advanced Endoscopy Trainees: The Rapid Assessment of Trainee Endoscopy Skills Study.

Wani S, Keswani R, Hall M, Han S, Ali MA, Brauer B, Carlin L, Chak A, Collins D, Cote GA, Diehl DL, DiMaio CJ, Dries A, El-Hajj I, Ellert S, Fairley K, Faulx A, Fujii-Lau L, Gaddam S, Gan SI, Gaspar JP, Gautamy C, Gordon S, Harris C, Hyder S, Jones R, Kim S, Komanduri S, Law R, Lee L, Mounzer R, Mullady D, Muthusamy VR, Olyaee M, Pfau P, Saligram S, Piraka C, Rastogi A, Rosenkranz L, Rzouq F, Saxena A, Shah RJ, Simon VC, Small A, Sreenarasimhaiah J, Walker A, Wang AY, Watson RR, Wilson RH, Yachimski P, Yang D, Edmundowicz S, Early DS.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1758-1767.e11. doi: 10.1016/j.cgh.2017.06.012. Epub 2017 Jun 16.

25.

Visceral Adiposity Predicts Severity of Acute Pancreatitis.

Natu A, Stevens T, Kang L, Yasinow S, Mansoor E, Lopez R, Glessing B, Remer E, Richards T, Gupta A, Chak A, Lee PJW.

Pancreas. 2017 Jul;46(6):776-781. doi: 10.1097/MPA.0000000000000845.

PMID:
28609366
26.

Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S.

Gastrointest Endosc. 2017 Jul;86(1):1-17.e3. doi: 10.1016/j.gie.2017.03.010. Epub 2017 May 30. Review. No abstract available.

PMID:
28576294
27.

Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S.

Am J Gastroenterol. 2017 Jul;112(7):1032-1048. doi: 10.1038/ajg.2017.166. Epub 2017 Jun 1. Review. No abstract available.

PMID:
28570552
28.

Erratum to: Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.

Kaz AM, Wong CJ, Varadan V, Willis JE, Chak A, Grady WM.

Clin Epigenetics. 2017 Mar 1;9:23. doi: 10.1186/s13148-017-0324-8. eCollection 2017.

29.

Response.

Krishnamoorthi R, Borah B, Heien H, Das A, Chak A, Iyer PG.

Gastrointest Endosc. 2017 Feb;85(2):463-464. doi: 10.1016/j.gie.2016.09.036. No abstract available.

PMID:
28089041
30.
31.

RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas.

Blum AE, Venkitachalam S, Guo Y, Kieber-Emmons AM, Ravi L, Chandar AK, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Barnholtz-Sloan JS, Markowitz SD, Willis JE, Shyr Y, Chak A, Varadan V, Guda K.

Cancer Res. 2016 Oct 1;76(19):5628-5633. Epub 2016 Aug 8.

32.

Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas.

Sun X, Elston R, Falk GW, Grady WM, Faulx A, Mittal SK, Canto MI, Shaheen NJ, Wang JS, Iyer PG, Abrams JA, Willis JE, Guda K, Markowitz S, Barnholtz-Sloan JS, Chandar A, Brock W, Chak A.

Mol Genet Genomic Med. 2016 Mar 14;4(4):407-19. doi: 10.1002/mgg3.211. eCollection 2016 Jul.

33.

Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.

Fecteau RE, Kong J, Kresak A, Brock W, Song Y, Fujioka H, Elston R, Willis JE, Lynch JP, Markowitz SD, Guda K, Chak A.

JAMA Oncol. 2016 Oct 1;2(10):1333-1339. doi: 10.1001/jamaoncol.2016.2054.

34.

Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.

Thota PN, Zackria S, Sanaka MR, Patil D, Goldblum J, Lopez R, Chak A.

J Clin Gastroenterol. 2017 May/Jun;51(5):402-406. doi: 10.1097/MCG.0000000000000559.

35.

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.

Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1412-1419.e3. doi: 10.1016/j.cgh.2016.05.032. Epub 2016 Jun 2.

36.

A Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's Esophagus.

Curtius K, Wong CJ, Hazelton WD, Kaz AM, Chak A, Willis JE, Grady WM, Luebeck EG.

PLoS Comput Biol. 2016 May 11;12(5):e1004919. doi: 10.1371/journal.pcbi.1004919. eCollection 2016 May. Erratum in: PLoS Comput Biol. 2017 Mar 17;13(3):e1005439.

37.

Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.

Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, Singh VK, Varadurajulu S, Vargo JJ, Willingham FF, Baron TH, Coté GA, Romagnuolo J, Wood-Williams A, Depue EK, Spitzer RL, Spino C, Foster LD, Durkalski V; SVI study group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE).

Trials. 2016 Mar 3;17(1):120. doi: 10.1186/s13063-016-1251-2.

38.

Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm.

Sun X, Elston RC, Barnholtz-Sloan JS, Falk GW, Grady WM, Faulx A, Mittal SK, Canto M, Shaheen NJ, Wang JS, Iyer PG, Abrams JA, Tian YD, Willis JE, Guda K, Markowitz SD, Chandar A, Warfe JM, Brock W, Chak A.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):727-35. doi: 10.1158/1055-9965.EPI-15-0832. Epub 2016 Feb 29.

39.

Can endosheath technology open primary care doors to Barrett's esophagus screening by transnasal endoscopy?

Iyer PG, Chak A.

Endoscopy. 2016 Feb;48(2):105-6. doi: 10.1055/s-0034-1393561. Epub 2016 Jan 28. No abstract available.

40.

Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population.

Cummings LC, Kou TD, Schluchter MD, Chak A, Cooper GS.

Gastrointest Endosc. 2016 Aug;84(2):232-240.e1. doi: 10.1016/j.gie.2016.01.019. Epub 2016 Jan 19.

41.

Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.

Krishnamoorthi R, Borah B, Heien H, Das A, Chak A, Iyer PG.

Gastrointest Endosc. 2016 Jul;84(1):40-46.e7. doi: 10.1016/j.gie.2015.12.036. Epub 2016 Jan 7.

42.

Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus.

Yu M, O'Leary RM, Kaz AM, Morris SM, Carter KT, Chak A, Chandar A, Willis JE, Moinova HR, Markowitz SD, Brenner DE, Anandabapasathy S, Westerhoff M, Wong CJ, Shaheen NJ, Chen Y, Barnholtz-Sloan JS, Grady WM.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1890-7. doi: 10.1158/1055-9965.EPI-15-0370. Epub 2015 Nov 6.

43.

Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.

Singh A, Chak A.

Gastroenterol Rep (Oxf). 2015 Nov;3(4):303-15. doi: 10.1093/gastro/gov048. Epub 2015 Oct 19. Review.

44.

Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.

Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R, Goldblum J, Gress F, Ilson DH, Inadomi JM, Kuipers EJ, Lynch JP, McKeon F, Metz D, Pasricha PJ, Pech O, Peek R, Peters JH, Repici A, Seewald S, Shaheen NJ, Souza RF, Spechler SJ, Vennalaganti P, Wang K.

Gastroenterology. 2015 Nov;149(6):1599-606. doi: 10.1053/j.gastro.2015.08.007. Epub 2015 Aug 19.

45.

Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis.

Chandar AK, Devanna S, Lu C, Singh S, Greer K, Chak A, Iyer PG.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2241-55.e1-4; quiz e179. doi: 10.1016/j.cgh.2015.06.041. Epub 2015 Jul 15. Review.

46.

Barrett's oesophagus diagnostic criteria: endoscopy and histology.

Naini BV, Chak A, Ali MA, Odze RD.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):77-96. doi: 10.1016/j.bpg.2014.11.004. Epub 2014 Nov 13. Review.

PMID:
25743458
47.

Associations of Serum Adiponectin and Leptin With Barrett's Esophagus.

Greer KB, Falk GW, Bednarchik B, Li L, Chak A.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2265-72. doi: 10.1016/j.cgh.2015.02.037. Epub 2015 Feb 28.

48.

Management of pancreatic cysts in an evidence-based world.

Moayyedi P, Weinberg DS, Schünemann H, Chak A.

Gastroenterology. 2015 Apr;148(4):692-5. doi: 10.1053/j.gastro.2015.02.035. Epub 2015 Feb 24. No abstract available.

PMID:
25724461
49.

Serum levels of retinol-binding protein 4 and risk of colon adenoma.

Abola MV, Thompson CL, Chen Z, Chak A, Berger NA, Kirwan JP, Li L.

Endocr Relat Cancer. 2015 Apr;22(2):L1-4. doi: 10.1530/ERC-14-0429. No abstract available.

50.

EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses.

Fujii-Lau LL, Abu Dayyeh BK, Bruno MJ, Chang KJ, DeWitt JM, Fockens P, Forcione D, Napoleon B, Palazzo L, Topazian MD, Wiersema MJ, Chak A, Clain JE, Faigel DO, Gleeson FC, Hawes R, Iyer PG, Rajan E, Stevens T, Wallace MB, Wang KK, Levy MJ.

Gastrointest Endosc. 2015 May;81(5):1188-96.e1-7. doi: 10.1016/j.gie.2014.10.035. Epub 2015 Feb 7.

Supplemental Content

Support Center